InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

SHOULDER INNOVATIONS, INC.

SI Clue Score60
United States Fiscal year ends December CIK 0001699350
$18.13 +1.34% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $18.13 +37.87% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Jul 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue31.6Operating income−14.7Net income−15.6EPS, diluted−242.04Fiscal year 2025Revenue47.3 +49.6%Operating income−26.3Net income−40.4EPS, diluted−4.65
FY2024FY2025
Revenue 31.6 47.3
Growth +49.6%
Operating income −14.7 −26.3
Net income −15.6 −40.4
Growth
EPS, diluted −242.04 −4.65

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2024Gross margin77.0%Operating margin−46.3%Net margin−49.4%Free cash flow margin−57.4%Fiscal year 2025Gross margin76.5%Operating margin−55.6%Net margin−85.3%Free cash flow margin−76.1%
FY2024FY2025
Gross margin 77.0% 76.5%
Operating margin −46.3% −55.6%
Net margin −49.4% −85.3%
Free cash flow margin −57.4% −76.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−14.1Capital expenditure−4.0Free cash flow−18.2Fiscal year 2025Operating cash flow−28.6Capital expenditure−7.4Free cash flow−36.0
FY2024FY2025
Operating cash flow −14.1 −28.6
Capital expenditure −4.0 −7.4
Free cash flow −18.2 −36.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2024Cash6.1Total debt14.7Net cash (debt)−8.5Shareholders’ equity−54.7Fiscal year 2025Cash26.9Total debt14.9Net cash (debt)12.0Shareholders’ equity140.8Debt to equity0.11
FY2024FY2025
Cash 6.1 26.9
Total debt 14.7 14.9
Net cash (debt) −8.5 12.0
Shareholders’ equity −54.7 140.8
Debt to equity n/a 0.11

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
77.0% 76.5%
−46.3% −55.6%
−49.4% −85.3%
−49.4% −85.3%
−57.4% −76.1%
Spending
14.2% 16.3%
109.1% 115.7%
12.7% 15.7%
Returns
n/a −28.7%
−36.3% −23.8%
Balance and payout
n/a 0.11
54.1% 17.2%